Suivre
Jeremy M. Simon
Jeremy M. Simon
Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Adresse e-mail validée de ds.dfci.harvard.edu
Titre
Citée par
Citée par
Année
An integrated encyclopedia of DNA elements in the human genome
ENCODE Project Consortium
Nature 489 (7414), 57-74, 2012
16549*2012
The accessible chromatin landscape of the human genome
RE Thurman, E Rynes, R Humbert, J Vierstra, MT Maurano, E Haugen, ...
Nature 489 (7414), 75-82, 2012
30422012
A map of open chromatin in human pancreatic islets
KJ Gaulton, T Nammo, L Pasquali, JM Simon, PG Giresi, MP Fogarty, ...
Nature genetics 42 (3), 255-259, 2010
6462010
Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity
L Song, Z Zhang, LL Grasfeder, AP Boyle, PG Giresi, BK Lee, ...
Genome research 21 (10), 1757-1767, 2011
6202011
Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA
JM Simon, PG Giresi, IJ Davis, JD Lieb
Nature protocols 7 (2), 256-267, 2012
4012012
Single-cell transcriptomic analysis of mouse neocortical development
L Loo, JM Simon, L Xing, ES McCoy, JK Niehaus, J Guo, ES Anton, ...
Nature communications 10 (1), 134, 2019
2452019
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation
GP Souroullas, WR Jeck, JS Parker, JM Simon, JY Liu, J Paulk, J Xiong, ...
Nature medicine 22 (6), 632-640, 2016
2092016
Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
JM Simon, KE Hacker, D Singh, AR Brannon, JS Parker, M Weiser, TH Ho, ...
Genome research 24 (2), 241-250, 2014
2052014
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
J Zhang, T Wu, J Simon, M Takada, R Saito, C Fan, XD Liu, E Jonasch, ...
Science 361 (6399), 290-295, 2018
1392018
BRG1/SMARCA4 inactivation promotes non–small cell lung cancer aggressiveness by altering chromatin organization
T Orvis, A Hepperla, V Walter, S Song, J Simon, J Parker, MD Wilkerson, ...
Cancer research 74 (22), 6486-6498, 2014
1332014
Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration
BL Pearson, JM Simon, ES McCoy, G Salazar, G Fragola, MJ Zylka
Nature communications 7 (1), 11173, 2016
1272016
Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription
M Patel, JM Simon, MD Iglesia, SB Wu, AW McFadden, JD Lieb, IJ Davis
Genome research 22 (2), 259-270, 2012
1252012
Gene length matters in neurons
MJ Zylka, JM Simon, BD Philpot
Neuron 86 (2), 353-355, 2015
1182015
Molecular classification of Crohn's disease reveals two clinically relevant subtypes
M Weiser, JM Simon, B Kochar, A Tovar, JW Israel, A Robinson, ...
Gut, gutjnl-2016-312518, 2016
1172016
Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA
JM Wolter, H Mao, G Fragola, JM Simon, JL Krantz, HO Bazick, B Oztemiz, ...
Nature 587 (7833), 281-284, 2020
1062020
A myelin-related transcriptomic profile is shared by Pitt–Hopkins syndrome models and human autism spectrum disorder
BDN Phan, JF Bohlen, BA Davis, Z Ye, HY Chen, B Mayfield, SR Sripathy, ...
Nature neuroscience 23 (3), 375-385, 2020
912020
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
JK Ocasio, B Babcock, D Malawsky, SJ Weir, L Loo, JM Simon, MJ Zylka, ...
Nature communications 10 (1), 5829, 2019
862019
Primary Cilia Signaling Promotes Axonal Tract Development and Is Disrupted in Joubert Syndrome-Related Disorders Models
J Guo, JM Otis, SK Suciu, C Catalano, L Xing, S Constable, D Wachten, ...
Developmental Cell 51 (6), 759-774. e5, 2019
802019
Spinal macrophages resolve nociceptive hypersensitivity after peripheral injury
JK Niehaus, B Taylor-Blake, L Loo, JM Simon, MJ Zylka
Neuron 109 (8), 1274-1282. e6, 2021
772021
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma
RS McNeill, DA Canoutas, TJ Stuhlmiller, HD Dhruv, DM Irvin, RE Bash, ...
Neuro-oncology 19 (11), 1469-1480, 2017
572017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20